Literature DB >> 29985119

Freezing of gait in Parkinson's disease: functional neuroimaging studies of the frontal lobe.

María José Gallardo1, Juan Pablo Cabello1, María Jesus Corrales1, Javier Torres-Donaire2, Jose Javier Bravo1, María Prado Talavera3, Alberto León1, Julia Vaamonde-Gamo1.   

Abstract

OBJECTIVE: The objective of the study is to study a group of patients with Parkinson's disease (PD) with and without freezing of gait (FOG) and analyze neuropsychological differences, especially regarding executive functions, according to their performance in a set of tests, and potential anomalies in functional positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography (18F-FDG PET/CT) neuroimaging results of the frontal lobe.
METHODS: The study recruited 23 patients. We performed an 18F-FDG PET/CT scan for 17 patients (9 with FOG and 8 without FOG) and 6 controls. Frontal functions were evaluated in all the patients during their 'on' situation.
RESULTS: In FDG PET studies, PD patients differed from controls in that they presented hypometabolic areas in the parietal and bilateral occipital regions, as well as in the bilateral frontal region, especially on the right side. Compared to patients without FOG, patients with FOG displayed more pronounced frontal and predominantly right-sided hypometabolism. Both groups of patients displayed a poorer performance than the control population in the frontal cognitive tests. A greater executive disfunction was found in patients with FOG.
CONCLUSIONS: Our study revealed greater hypometabolism in FDG PET studies, predominantly in right-sided-specific motor regions of the frontal lobe in FOG patients and greater frontal disfunction in neuropsychological tests in PD patients with FOG. These data suggest that FOG may be related to functional impairment of the circuits connecting the frontal lobe and the basal ganglia.

Entities:  

Keywords:  18F-FDG PET/CT scan; Freezing of gait; executive functions; frontal lobe

Mesh:

Substances:

Year:  2018        PMID: 29985119     DOI: 10.1080/01616412.2018.1484985

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  Alterations in Degree Centrality and Functional Connectivity in Parkinson's Disease Patients With Freezing of Gait: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  MiaoRan Guo; Yan Ren; HongMei Yu; HuaGuang Yang; ChengHao Cao; YingMei Li; GuoGuang Fan
Journal:  Front Neurosci       Date:  2020-11-03       Impact factor: 4.677

Review 2.  Neuroimaging advances in Parkinson's disease with freezing of gait: A systematic review.

Authors:  Komal Bharti; Antonio Suppa; Silvia Tommasin; Alessandro Zampogna; Sara Pietracupa; Alfredo Berardelli; Patrizia Pantano
Journal:  Neuroimage Clin       Date:  2019-11-09       Impact factor: 4.881

3.  Brain networks associated with anticipatory postural adjustments in Parkinson's disease patients with freezing of gait.

Authors:  Andrea C de Lima-Pardini; Daniel B Coelho; Mariana P Nucci; Catarina C Boffino; Alana X Batista; Raymundo M de Azevedo Neto; Carla Silva-Batista; Egberto R Barbosa; Rajal G Cohen; Fay B Horak; Luis A Teixeira; Edson Amaro
Journal:  Neuroimage Clin       Date:  2020-10-08       Impact factor: 4.881

4.  Dopaminergic pathways and resting-state functional connectivity in Parkinson's disease with freezing of gait.

Authors:  Kenan Steidel; Marina C Ruppert; Irina Palaghia; Andrea Greuel; Masoud Tahmasian; Franziska Maier; Jochen Hammes; Thilo van Eimeren; Lars Timmermann; Marc Tittgemeyer; Alexander Drzezga; David Pedrosa; Carsten Eggers
Journal:  Neuroimage Clin       Date:  2021-11-29       Impact factor: 4.881

Review 5.  Spinal Cord Stimulation for Freezing of Gait: From Bench to Bedside.

Authors:  Erich Talamoni Fonoff; Andrea C de Lima-Pardini; Daniel Boari Coelho; Bernardo Assumpção Monaco; Birajara Machado; Carolina Pinto de Souza; Maria Gabriela Dos Santos Ghilardi; Clement Hamani
Journal:  Front Neurol       Date:  2019-08-27       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.